|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
723.09(B) |
Last
Volume: |
3,201,799 |
Avg
Vol: |
3,291,238 |
52
Week Range: |
$423.21 - $792.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 720 |
Guru Rank Value : 1.4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
656 |
Total Buy Value |
$0 |
$0 |
$0 |
$199,549 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
435,750 |
871,420 |
2,951,506 |
6,211,418 |
Total Sell Value |
$330,574,311 |
$608,633,217 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
2 |
2 |
5 |
6 |
Total Sell Transactions |
5 |
14 |
46 |
89 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Greene Gabrielle E |
Director |
|
2023-05-15 |
4 |
A |
$434.51 |
$4,780 |
D/D |
11 |
1,659 |
|
- |
|
Johnson Kimberly H |
Director |
|
2023-05-15 |
4 |
A |
$434.51 |
$9,559 |
D/D |
22 |
2,094 |
|
- |
|
Alvarez Ralph |
Director |
|
2023-05-15 |
4 |
A |
$434.51 |
$11,297 |
D/D |
26 |
53,051 |
|
- |
|
Luciano Juan R |
Director |
|
2023-05-15 |
4 |
A |
$434.51 |
$14,339 |
D/D |
33 |
14,951 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2023-05-15 |
4 |
A |
$434.51 |
$9,994 |
D/D |
23 |
953 |
|
- |
|
Zakrowski Donald A |
SVP, Finance, & CAO |
|
2023-05-15 |
4 |
AS |
$435.29 |
$261,174 |
D/D |
(600) |
5,978 |
|
27% |
|
Lilly Endowment Inc |
10% Owner |
|
2023-05-12 |
4 |
S |
$442.25 |
$9,141,436 |
D/D |
(20,646) |
101,668,164 |
|
-27% |
|
Lilly Endowment Inc |
10% Owner |
|
2023-05-03 |
4 |
S |
$415.72 |
$76,028,738 |
D/D |
(178,302) |
101,688,810 |
|
-39% |
|
Lilly Endowment Inc |
10% Owner |
|
2023-05-02 |
4 |
S |
$408.72 |
$17,085,592 |
D/D |
(41,698) |
101,867,112 |
|
-47% |
|
Lilly Endowment Inc |
10% Owner |
|
2023-04-28 |
4 |
S |
$395.36 |
$89,657,657 |
D/D |
(225,000) |
101,908,810 |
|
-45% |
|
Johnson Kimberly H |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$9,681 |
D/D |
26 |
2,072 |
|
- |
|
Greene Gabrielle E |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$4,841 |
D/D |
13 |
1,648 |
|
- |
|
Fyrwald J Erik |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$10,053 |
D/D |
27 |
70,949 |
|
- |
|
Tai Jackson P |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$1,862 |
D/D |
5 |
63,524 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$10,053 |
D/D |
27 |
930 |
|
- |
|
Alvarez Ralph |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$11,171 |
D/D |
30 |
53,025 |
|
- |
|
Luciano Juan R |
Director |
|
2023-04-17 |
4 |
A |
$372.35 |
$14,522 |
D/D |
39 |
14,918 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2023-04-06 |
4 |
S |
$364.98 |
$47,853,821 |
D/D |
(130,297) |
102,133,810 |
|
-48% |
|
Lilly Endowment Inc |
10% Owner |
|
2023-04-05 |
4 |
S |
$363.24 |
$25,327,917 |
D/D |
(69,703) |
102,264,107 |
|
-51% |
|
Lilly Endowment Inc |
10% Owner |
|
2023-03-24 |
4 |
S |
$335.75 |
$67,164,555 |
D/D |
(200,000) |
102,748,810 |
|
-34% |
|
Johnson Kimberly H |
Director |
|
2023-03-20 |
4 |
A |
$333.60 |
$9,674 |
D/D |
29 |
2,046 |
|
- |
|
Greene Gabrielle E |
Director |
|
2023-03-20 |
4 |
A |
$333.60 |
$5,004 |
D/D |
15 |
1,635 |
|
- |
|
Alvarez Ralph |
Director |
|
2023-03-20 |
4 |
A |
$333.60 |
$11,342 |
D/D |
34 |
52,995 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2023-03-20 |
4 |
A |
$333.60 |
$10,008 |
D/D |
30 |
655 |
|
- |
|
Fyrwald J Erik |
Director |
|
2023-03-20 |
4 |
A |
$333.60 |
$10,008 |
D/D |
30 |
70,922 |
|
- |
|
3297 Records found
|
|
Page 7 of 132 |
|
|